Cost Analysis of Erlotinib Versus Chemotherapy for First-Line Treatment of Non–Small-Cell Lung Cancer in Frail Elderly Patients Participating in a Prospective Phase 2 Study (GFPC 0505)

Christos Chouaid; Hervé Le Caer; Romain Corre; Jacquy Crequit; Chrystelle Locher; Lionel Falchero; Cecile Dujon; Henri Berard; Isabelle Monnet; Alain Vergnenegre

doi:10.1016/j.cllc.2012.04.006

Cost Analysis of Erlotinib Versus Chemotherapy for First-Line Treatment of Non–Small-Cell Lung Cancer in Frail Elderly Patients Participating in a Prospective Phase 2 Study (GFPC 0505)

Clinical Lung Cancer ◽

10.1016/j.cllc.2012.04.006 ◽

2013 ◽

Vol 14 (2) ◽

pp. 103-107 ◽

Cited By ~ 8

Author(s):

Christos Chouaid ◽

Hervé Le Caer ◽

Romain Corre ◽

Jacquy Crequit ◽

Chrystelle Locher ◽

...

Keyword(s):

Lung Cancer ◽

Elderly Patients ◽

Small Cell ◽

Line Treatment ◽

Phase 2 ◽

Small Cell Lung ◽

First Line ◽

Phase 2 Study ◽

Prospective Phase ◽

First Line Treatment

Download Full-text

Cost effectivenes of erlotinib versus chemotherapy for first-line treatment of non small cell lung cancer (NSCLC) in fit elderly patients participating in a prospective phase 2 study (GFPC 0504)

BMC Cancer ◽

10.1186/1471-2407-12-301 ◽

2012 ◽

Vol 12 (1) ◽

Cited By ~ 8

Author(s):

Chouaid Christos ◽

◽

Le Caer Hervé ◽

Locher Chrystelle ◽

Dujon Cecile ◽

...

Keyword(s):

Lung Cancer ◽

Elderly Patients ◽

Small Cell ◽

Line Treatment ◽

Phase 2 ◽

Small Cell Lung ◽

First Line ◽

Phase 2 Study ◽

Prospective Phase ◽

First Line Treatment

Download Full-text

PCN84 COST-EFFECTIVENESS OF ERLOTINIB IN FIRST-LINE TREATMENT OF ADVANCED NON-SMALL CELL LUNG CANCER (NSCLC) IN FIT ELDERLY PATIENTS: AN ECONOMICAL ANALYSIS OF A PROSPECTIVE PHASE 2 STUDY (GFPC 0504)

Value in Health ◽

10.1016/s1098-3015(11)71979-9 ◽

2010 ◽

Vol 13 (7) ◽

pp. A267 ◽

Cited By ~ 2

Author(s):

C Chouaid ◽

H Lecaer ◽

J Crequit ◽

I Monnet ◽

S Chouabe ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell ◽

Line Treatment ◽

Phase 2 ◽

Small Cell Lung ◽

First Line ◽

Economical Analysis ◽

Phase 2 Study ◽

Prospective Phase ◽

First Line Treatment

Download Full-text

9095 POSTER Prospective Phase II Trial of a Combination of Gemcitabine and UFT as First-line Treatment in Elderly Patients With Advanced Non-small Cell Lung Cancer

European Journal of Cancer ◽

10.1016/s0959-8049(11)72407-8 ◽

2011 ◽

Vol 47 ◽

pp. S621

Author(s):

J. Baek ◽

J. Ahn ◽

Y. Jegal ◽

C. Park ◽

Y. Lee ◽

...

Keyword(s):

Lung Cancer ◽

Elderly Patients ◽

Small Cell Lung Cancer ◽

Phase Ii Trial ◽

Small Cell ◽

Line Treatment ◽

Small Cell Lung ◽

First Line ◽

Prospective Phase ◽

First Line Treatment

Download Full-text

Prospective phase II trial of a combination of gemcitabine and UFT as first-line treatment in elderly patients with advanced non-small cell lung cancer

Lung Cancer ◽

10.1016/j.lungcan.2011.11.021 ◽

2012 ◽

Vol 76 (3) ◽

pp. 368-372 ◽

Cited By ~ 1

Author(s):

Jin Ho Baek ◽

Hawk Kim ◽

Jong-Joon Ahn ◽

Yangjin Jegal ◽

Kwang Won Seo ◽

...

Keyword(s):

Lung Cancer ◽

Elderly Patients ◽

Small Cell Lung Cancer ◽

Phase Ii Trial ◽

Small Cell ◽

Line Treatment ◽

Small Cell Lung ◽

First Line ◽

Prospective Phase ◽

First Line Treatment

Download Full-text

Bevacizumab combined with pemetrexed plus cisplatin followed by maintenance bevacizumab/pemetrexed as first-line treatment of advanced non-squamous non-small cell lung cancer: A single-arm Phase 2 study

Lung Cancer ◽

10.1016/j.lungcan.2014.07.003 ◽

2014 ◽

Vol 86 (1) ◽

pp. 47-53

Author(s):

Armando Santoro ◽

Gunnar N. Hillerdal ◽

Gert Hoeffken ◽

Adolfo Favaretto ◽

Ramon Perez Carrion ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Cell Lung Cancer ◽

Small Cell ◽

Line Treatment ◽

Phase 2 ◽

Small Cell Lung ◽

First Line ◽

Phase 2 Study ◽

First Line Treatment

Download Full-text

A Randomized Phase 2 Study of Paclitaxel and Carboplatin with or without Conatumumab for First-Line Treatment of Advanced Non–Small-Cell Lung Cancer

Journal of Thoracic Oncology ◽

10.1097/jto.0b013e31827ce554 ◽

2013 ◽

Vol 8 (3) ◽

pp. 329-337 ◽

Cited By ~ 44

Author(s):

Luis Paz-Ares ◽

Beatrix Bálint ◽

Richard H. de Boer ◽

Jan P. van Meerbeeck ◽

Rafal Wierzbicki ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Small Cell ◽

Line Treatment ◽

Phase 2 ◽

Small Cell Lung ◽

First Line ◽

Phase 2 Study ◽

Randomized Phase 2 ◽

First Line Treatment

Download Full-text

PCN79 Cost Effectiveness of Erlotinib in First Line Treatment of Advanced Non Small Cell Lung Cancer (NSCLC) in Vulnerable Elderly Patients: An Economical Analysis of a prospective Phase 2 Study (GFPC 0505)

Value in Health ◽

10.1016/j.jval.2011.08.1180 ◽

2011 ◽

Vol 14 (7) ◽

pp. A448 ◽

Cited By ~ 1

Author(s):

C. Chouaid ◽

H. Le Caer ◽

R. Corre ◽

J. Crequit ◽

H. Jullian ◽

...

Keyword(s):

Small Cell ◽

Line Treatment ◽

Phase 2 ◽

Small Cell Lung ◽

First Line ◽

Economical Analysis ◽

Phase 2 Study ◽

Prospective Phase ◽

Vulnerable Elderly ◽

First Line Treatment

Download Full-text

Doublet Versus Single Cytotoxic Agent as First-Line Treatment for Elderly Patients with Advanced Non-Small-Cell Lung Cancer: A Systematic Review and Meta-Analysis

Lung ◽

10.1007/s00408-012-9399-3 ◽

2012 ◽

Vol 190 (5) ◽

pp. 477-485 ◽

Cited By ~ 23

Author(s):

Wei-Xiang Qi ◽

Li-na Tang ◽

Ai-na He ◽

Zan Shen ◽

Feng Lin ◽

...

Keyword(s):

Lung Cancer ◽

Systematic Review ◽

Elderly Patients ◽

Small Cell Lung Cancer ◽

Meta Analysis ◽

Small Cell ◽

Line Treatment ◽

Small Cell Lung ◽

First Line ◽

First Line Treatment

Download Full-text

Clinical effect of erlotinib as first-line treatment for Asian elderly patients with advanced non-small-cell lung cancer

Cancer Chemotherapy and Pharmacology ◽

10.1007/s00280-010-1450-6 ◽

2010 ◽

Vol 67 (2) ◽

pp. 475-479 ◽

Cited By ~ 8

Author(s):

Xin-Hua Xu ◽

Jin Su ◽

Xiang-Yang Fu ◽

Feng Xue ◽

Qiao Huang ◽

...

Keyword(s):

Lung Cancer ◽

Elderly Patients ◽

Small Cell Lung Cancer ◽

Cell Lung Cancer ◽

Clinical Effect ◽

Small Cell ◽

Line Treatment ◽

Small Cell Lung ◽

First Line ◽

First Line Treatment

Download Full-text

A Phase II Study of S‐1 and Paclitaxel Combination Therapy as a First‐Line Treatment in Elderly Patients with Advanced Non‐Small Cell Lung Cancer

The Oncologist ◽

10.1634/theoncologist.2018-0858 ◽

2018 ◽

Vol 24 (4) ◽

pp. 459 ◽

Cited By ~ 2

Author(s):

Akihiro Yoshimura ◽

Yusuke Chihara ◽

Koji Date ◽

Nobuyo Tamiya ◽

Yoshizumi Takemura ◽

...

Keyword(s):

Lung Cancer ◽

Combination Therapy ◽

Elderly Patients ◽

Small Cell Lung Cancer ◽

Phase Ii Study ◽

Small Cell ◽

Line Treatment ◽

Small Cell Lung ◽

First Line ◽

First Line Treatment

Download Full-text